Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

• Megha Verma ,

  * E-mail: mverma@roskampinstitute.net

  Affiliations The Roskamp Institute, Sarasota, Florida, 34243, United States of America, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, United Kingdom

  ⨯
• David Beaulieu-Abdelahad,

  Affiliation The Roskamp Institute, Sarasota, Florida, 34243, United States of America

  ⨯
• Ghania Ait-Ghezala,

  Affiliation The Roskamp Institute, Sarasota, Florida, 34243, United States of America

  ⨯
• Rena Li,

  Affiliation The Roskamp Institute, Sarasota, Florida, 34243, United States of America

  ⨯
• Fiona Crawford,

  Affiliation The Roskamp Institute, Sarasota, Florida, 34243, United States of America

  ⨯
• Michael Mullan,

  Affiliations The Roskamp Institute, Sarasota, Florida, 34243, United States of America, Rock Creek Pharmaceuticals, Sarasota, Florida, 34243, United States of America

  ⨯
• Daniel Paris

  Affiliation The Roskamp Institute, Sarasota, Florida, 34243, United States of America

  ⨯